KOSPI Declines Over 1% Despite Foreign and Institutional Buying

The KOSPI is showing a decline of over 1%. Concerns about a 'Black Thursday' have increased due to a drop in the U.S. stock market, a surge in long-term Treasury yields, and geopolitical risks in the Middle East. However, the decline has been limited to the 1% range thanks to buying from foreign and institutional investors.

As of 1:19 PM on July 30, the KOSPI was down 97.16 points (1.72%) at 5,566.08. The index opened at 5,681.77, up 18.53 points (0.33%) from the previous trading day, but quickly turned downward before fluctuating again. In the afternoon, it widened its losses, falling to the 5,560 range.

In the securities market, foreign and institutional investors have net bought 675.8 billion won and 880.1 billion won, respectively. In contrast, individual investors have net sold 1.545 trillion won, taking profits.

The top stocks by market capitalization in the KOSPI are mixed. Samsung Electronics (up 0.48%), LG Energy Solution (up 5.16%), Samsung Biologics (up 0.88%), and KB Financial (up 3.69%) are gaining. Meanwhile, SK Hynix (down 4.93%), SK Square (down 7.65%), Hyundai Motor (down 1.70%), Samsung Electro-Mechanics (down 10.40%), and Samsung Life Insurance (down 1.32%) are experiencing losses.

At the same time, the KOSDAQ index recorded a decline of 16.30 points (2.46%), standing at 646.38. The index opened at 654.72, down 7.96 points (1.20%), and while it briefly turned upward during the day, it returned to a downward trend, showing continued volatility.

In the KOSDAQ market, individual and institutional investors have net sold 30.7 billion won and 49.7 billion won, respectively, while foreign investors have net bought 75.5 billion won.

The top stocks by market capitalization in the KOSDAQ are also showing mixed results. Alteogen (up 0.35%), EcoPro (up 4.90%), and EcoPro BM (up 5.29%) are rising. Conversely, Rainbow Robotics (down 7.43%), Juseong Engineering (down 14.81%), Rino Industry (down 4.81%), HLB (down 4.00%), Wonik IPS (down 7.57%), Pharma Research (down 9.72%), and ABL Bio (down 2.53%) are declining.

* This article has been translated by AI.